113 related articles for article (PubMed ID: 15893918)
1. Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.
in 't Veen JP; van den Berg MP; Romeijn SG; Verhoef JC; Merkus FW
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):27-31. PubMed ID: 15893918
[TBL] [Abstract][Full Text] [Related]
2. Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.
van den Berg MP; Verhoef JC; Romeijn SG; Merkus FW
Eur J Pharm Biopharm; 2004 Jul; 58(1):131-5. PubMed ID: 15207546
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats.
Wang Q; Chen G
Biopharm Drug Dispos; 2009 Dec; 30(9):551-5. PubMed ID: 19780094
[TBL] [Abstract][Full Text] [Related]
4. Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans.
Van den Berg MP; Merkus P; Romeijn SG; Verhoef JC; Merkus FW
J Drug Target; 2003 Jul; 11(6):325-31. PubMed ID: 14668053
[TBL] [Abstract][Full Text] [Related]
5. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.
Sakane T; Akizuki M; Taki Y; Yamashita S; Sezaki H; Nadai T
J Pharm Pharmacol; 1995 May; 47(5):379-81. PubMed ID: 7494186
[TBL] [Abstract][Full Text] [Related]
6. [Preparation of huperzine A nasal in situ gel and evaluation of its brain targeting following intranasal administration].
Tao T; Zhao Y; Yue P; Dong WX; Chen QH
Yao Xue Xue Bao; 2006 Nov; 41(11):1104-10. PubMed ID: 17262956
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of Gastrodin in rat plasma and CSF after i.n. and i.v.
Wang Q; Chen G; Zeng S
Int J Pharm; 2007 Aug; 341(1-2):20-5. PubMed ID: 17482780
[TBL] [Abstract][Full Text] [Related]
8. Huperzine A in rat plasma and CSF following intranasal administration.
Yue P; Tao T; Zhao Y; Ren J; Chai X
Int J Pharm; 2007 Jun; 337(1-2):127-32. PubMed ID: 17241758
[TBL] [Abstract][Full Text] [Related]
9. Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.
van den Berg MP; Merkus P; Romeijn SG; Verhoef JC; Merkus FW
Pharm Res; 2004 May; 21(5):799-802. PubMed ID: 15180337
[TBL] [Abstract][Full Text] [Related]
10. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
Miyamoto M; Natsume H; Satoh I; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 2001 Sep; 226(1-2):127-38. PubMed ID: 11532576
[TBL] [Abstract][Full Text] [Related]
11. Visualization of in vivo olfactory uptake and transfer using fluorescein dextran.
Jansson B; Björk E
J Drug Target; 2002 Aug; 10(5):379-86. PubMed ID: 12442808
[TBL] [Abstract][Full Text] [Related]
12. Direct transport of VEGF from the nasal cavity to brain.
Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
[TBL] [Abstract][Full Text] [Related]
13. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
[TBL] [Abstract][Full Text] [Related]
14. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
15. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
16. Brain microdialysate, CSF and plasma pharmacokinetics of ligustrazine hydrochloride in rats after intranasal and intravenous administration.
Wang Q; Tang Z; Zhang W
Biopharm Drug Dispos; 2013 Oct; 34(7):417-22. PubMed ID: 23868712
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.
Wang Q; Zhang Y; Wong CH; Edwin Chan HY; Zuo Z
AAPS J; 2017 Dec; 20(1):23. PubMed ID: 29282567
[TBL] [Abstract][Full Text] [Related]
18. Aminated gelatin as a nasal absorption enhancer for peptide drugs: evaluation of absorption enhancing effect and nasal mucosa perturbation in rats.
Wang J; Sakai S; Deguchi Y; Bi D; Tabata Y; Morimoto K
J Pharm Pharmacol; 2002 Feb; 54(2):181-8. PubMed ID: 11848281
[TBL] [Abstract][Full Text] [Related]
19. Bioluminescent Study of the Distribution of High-Molecular-Weight Protein Fraction of Cellex Daily Preparation in the Brain after Intranasal Administation.
Baklaushev VP; Yusubalieva GM; Burenkov MS; Mel'nikov PA; Bozhko EA; Mentyukov GA; Lavrent'eva LS; Sokolov MA; Chekhonin VP
Bull Exp Biol Med; 2017 Dec; 164(2):285-292. PubMed ID: 29177876
[TBL] [Abstract][Full Text] [Related]
20. The potential of nasal application for delivery to the central brain-a microdialysis study of fluorescein in rats.
Bagger MA; Bechgaard E
Eur J Pharm Sci; 2004 Feb; 21(2-3):235-42. PubMed ID: 14757495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
